Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "EPL"

647 News Found

Cadila launches nutritional replenisher ‘Nu Nutridac’ capsule
News | September 16, 2025

Cadila launches nutritional replenisher ‘Nu Nutridac’ capsule

Nu Nutridac is a nutritional replenisher for neurodegenerative and anxiety-related disorders


Novo Nordisk taps Replicate Bioscience’s srRNA platform for obesity
News | August 31, 2025

Novo Nordisk taps Replicate Bioscience’s srRNA platform for obesity

Replicate will receive research funding and could potentially receive up to approximately US$550 million


Peter Bains to replace Jonathan Hunt as CEO of Syngene
People | February 11, 2025

Peter Bains to replace Jonathan Hunt as CEO of Syngene

Peter Bains has over three decades of experience in the biotech and pharmaceutical industry


Merck to acquire investigational B-Cell depletion therapy from Curon Biopharmaceutical
News | August 11, 2024

Merck to acquire investigational B-Cell depletion therapy from Curon Biopharmaceutical

CN201 is a next generation CD3xCD19 bispecific antibody that augments and diversifies Merck’s pipeline, with potential applications in B-cell malignancies and autoimmune diseases


Ecolab and Repligen launch DurA Cycle affinity resin for biologic manufacturing
News | June 09, 2024

Ecolab and Repligen launch DurA Cycle affinity resin for biologic manufacturing

DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,


Reclassify nicotine replacement therapies as prescription drugs, says Doctor
News | October 07, 2023

Reclassify nicotine replacement therapies as prescription drugs, says Doctor

NRT offers 50% higher success rate in quitting smoking compared to unassisted attempts


Robotic surgery enhances success rate in knee replacements
Healthcare | July 26, 2023

Robotic surgery enhances success rate in knee replacements

Through the use of robotic assisted orthopaedic surgeries, the success rate is close to 98%


Cheplapharm selects Generis’ CARA Life Sciences platform to unify their clinical processes
News | January 20, 2023

Cheplapharm selects Generis’ CARA Life Sciences platform to unify their clinical processes

Connectivity and harmonisation were both key driving factors behind our decision to choose the CARA Life Sciences Platform to consolidate our processes


De Nora and Aclarity sign agreement to deploy PFAS destroying technology
News | December 15, 2022

De Nora and Aclarity sign agreement to deploy PFAS destroying technology

The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally


Centre deploys three teams to manage high measles cases among children
News | November 24, 2022

Centre deploys three teams to manage high measles cases among children

The teams will assist the state health authorities in instituting public health measures and facilitate operationalization of requisite control and containment measures